Taken together, our in vitro and in vivo data are clearly supportive of emerging evidence highlighting cross-talk between PPARα and Nox2 as an important regulatory axis in CHF—the precise nature of which has not been previously defined in this setting. The gene discussed is CYBB; the disease is congestive heart failure.